Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
A cornerstone of scientific activity in many countries, cancer research is producing game-changing work for universal gain. But inequalities in the field risk blunting its potential to save lives. This Nature Index supplement explores the techniques that are fueling a treatment revolution and the countries that are fighting for their place in global cancer research, against the odds.
A description of the terminology and methodology used in this supplement, and a guide to the functionality that is available free online at natureindex.com.
Rapid advances in CAR-T-cell therapies and other personalized treatments mean that hospitals can now offer even more cleverly targeted cancer treatments.
An unparalleled bioresource bank and cutting-edge molecular and genomic techniques have put Japan’s National Cancer Center Research Institute at the forefront of cancer research.
Singapore has become a centre for cancer clinical trials thanks to a pioneering genetic mutation identification programme that matches late-stage cancer patients to therapeutic studies.
Early diagnosis of pancreatic cancer and a new way of treating hard-to-reach lung tumours are two ways that researchers in Japan are advancing on problematic cancers.
Japanese medical researchers are using world-leading robotics to provide minimally invasive gastric tract and prostate surgeries, and developing complex new organoids for personalized drug selection.